Page 6 - Sherif Louis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Telo Genomics Corp : Telo Genomics Launches Clinical Study of Drug Resistance Test for Multiple Myeloma

Toronto, Ontario (Newsfile Corp. - July 13, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") is pleased to announce that it has commenced the processing of clinical samples

United statesHugh rogersSherif louisNewsfile corpMars centreTelo genomics corpRegulation services providerVenture exchangeMayo clinicSouth tower

Telo Genomics Corp : Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples

Toronto, Ontario (Newsfile Corp. - July 6, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") announces the completion of the laboratory processing and analysis component

United statesHugh rogersSherif louisNewsfile corpMars centreTelo genomics corpRegulation services providerVenture exchangeCompany teloviewMayo clinicSouth tower

Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples

Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHugh rogersSherif louisNewsfile corpMars centreTelo genomics corpRegulation services providerVenture exchangeCompany teloviewMayo clinicSouth tower

Telo Genomics Corp : Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma

Toronto, Ontario (Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "TELO") announces that it has completed the validation of a suite of proprietary automation

United statesBasse normandieHugh rogersSherif louisMars centreNewsfile corpTelo genomics corpFrancois baclesse cancer centerCompany science technology committeeVenture exchangeRegulation services providerTechnology committeeMayo clinicSouth tower

Telo Genomics Corp : Telo Genomics Advances Its Lead Product and Implements Automation to Its Workflow

Toronto, Ontario (Newsfile Corp. - January 19, 2022) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") announces the launch of a validation study to accelerate the commercialization of its

United statesBasse normandieHugh rogersSherif louisHans knechtMars centreInternational myeloma workshopAmerican society of hematologyNewsfile corpHospital mcgill universityTelo genomics corpFrancois baclesse cancer centerVenture exchangeRegulation services providerJewish general hospitalMcgill university